1-17823024-G-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_030812.3(ACTL8):āc.16G>Cā(p.Val6Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000186 in 1,613,818 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_030812.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ACTL8 | NM_030812.3 | c.16G>C | p.Val6Leu | missense_variant | 2/3 | ENST00000375406.2 | NP_110439.2 | |
ACTL8 | XM_011542212.3 | c.16G>C | p.Val6Leu | missense_variant | 2/3 | XP_011540514.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ACTL8 | ENST00000375406.2 | c.16G>C | p.Val6Leu | missense_variant | 2/3 | 1 | NM_030812.3 | ENSP00000364555.1 | ||
ACTL8 | ENST00000617065.1 | c.16G>C | p.Val6Leu | missense_variant | 1/2 | 2 | ENSP00000481590.1 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152178Hom.: 0 Cov.: 33
GnomAD4 exome AF: 0.0000171 AC: 25AN: 1461640Hom.: 0 Cov.: 56 AF XY: 0.0000124 AC XY: 9AN XY: 727094
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152178Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74332
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 22, 2023 | The c.16G>C (p.V6L) alteration is located in exon 1 (coding exon 1) of the ACTL8 gene. This alteration results from a G to C substitution at nucleotide position 16, causing the valine (V) at amino acid position 6 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at